PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3719/12/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
Chiesi complained about GSK promotional materials for Trelegy (website pages, an embedded video and an ERS 2022 leavepiece).Four issues were escalated: (1) a rotating banner ad showing competitor i…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3690/8/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK
A non-contactable complainant (described as a concerned health professional) complained about a UK-based senior medical GSK employee reacting “loves this” to a LinkedIn post from a renowned can…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3609/2/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
Britannia Pharmaceuticals Ltd made a voluntary admission about incorrect prescribing information (PI) availability on the APO-go (apomorphine hydrochloride) promotional website, which was developed…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3620/3/22
Social Media & Digital Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Strides Pharma UK
An anonymous, contactable complainant (a pharmacist) challenged a Strides promotional poster for StritVit D3 (colecalciferol, vitamin D3) that stated “Nut and soya free, suitable for vegetarians�…
Clauses: 9.1,9.2
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3615/3/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached Code over uncertified mobile ‘final form’ differences on Lixiana HCP and pat
An anonymous, contactable complainant alleged Daiichi Sankyo had not properly certified mobile versions of Lixiana (edoxaban) webpages. On the HCP promotional site (lixiana-hcp.co.uk), the desktop …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3621/3/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi breached the ABPI Code after a third-party event email implied sponsorship of a prize draw tied to attending
A health professional complained about a reminder email for a MIMS Live Digital Event (21–23 March 2022) offering a chance to win a free annual subscription to MIMS Learning.To enter the draw, de…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3622/3/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A physician complained about a Medscape rolling banner advertisement for Forxiga (dapagliflozin), marketed by AstraZeneca.The complainant provided screenshots of frames 2–4; AstraZeneca provided …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3608/2/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A contactable complainant (self-described medical oncologist) alleged AstraZeneca promoted its current and future oncology pipeline to the public via LinkedIn.The LinkedIn post was made by a named …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3644/5/22
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Croma Pharma
An anonymous member of the public complained about a Croma Pharma Letybo (botulinum toxin type A) launch symposium held in Monaco in April 2022 (AUTH/3644/5/22); an identical complaint was later re…
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3595/1/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol Myers Squibb & Pfizer
A GP complainant challenged four patient information booklets hosted in the “patient materials” section of the Eliquis (apixaban) website, alleging they were not updated to reflect multiple SPC…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3601/1/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Boehringer Ingelheim
A concerned health professional complained about a dynamic digital banner advertisement for Trajenta (linagliptin) by Boehringer Ingelheim Limited.The banner included the claim: “Unique convenien…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3602/1/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva
A UK health professional complained about the Ajovy (fremanezumab) website (www.ajovy.co.uk), focusing on the initial landing-page pop-up.The pop-up asked users to confirm whether they were a healt…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3604/1/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK-based individual contracted to work for Novo Nordisk A/S (via a third-party talent acquisition company) posted on LinkedIn (approx. June 2021).The post referenced a planned phase 3a trial of �…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3611/2/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A health professional complained about an electronic NICE technology appraisal (TA694) summary card for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe), commissioned and funded by …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3612/2/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached Code over statin contraindication clarity and PI display time in live sympos
A health professional complained about a Daiichi Sankyo promotional symposium (live and later on-demand) for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) at a learned society vi…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3617/3/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
GSK employee’s personal LinkedIn post about “shingles prevention” and Shingrix role
An anonymous, non-contactable complainant (a self-described health professional) alleged Shingrix (herpes zoster vaccine) was promoted on LinkedIn.The complaint related to: (1) a personal LinkedIn …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3618/3/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca breached ABPI Code over Forxiga “start on 10mg” dosing claims hidden behind footnote (AU
An anonymous, contactable health professional complained about Forxiga (dapagliflozin) promotion by AstraZeneca. The complaint related to (1) a call with an AstraZeneca representative and (2) claim…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3623/3/22
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Aimmune
A former employee complained about a post on the Aimmune Therapeutics US LinkedIn account about presenting abstracts at WSAAI, referring to an OIT treatment for peanut allergy and naming “Peanut …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3630/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant (ex-employee) challenged the mobile view of Daiichi Sankyo’s promotional Lixiana (edoxaban) HCP website (ref EDX/22/0052, date of preparation March 2022). The complainant…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3640/5/22
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission about a promotional email to health professionals stating Novo Nordisk UK had no issues with supply of Ozempic (semaglutide) and Rybelsus (semaglutide) (GLP-…
Clauses: 9.1
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3603/1/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead (HIV.eu)
An anonymous UK health professional complained about Gilead Sciences Europe’s website HIV.eu, intended for healthcare professionals. The landing pop-up offered “CONTINUE TO SITE” (HCP) or “…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3711/11/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.5 over unclear involvement in pharmacist obesity hub and documents (A
A UK health professional complained about a password-protected weight management and obesity “hub” hosted on a UK pharmacist association’s website, developed under a Collaborative Working (CW…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3626/3/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous health professional complained about four articles in an online supplement: “2021, Volume 28, Supplement 2: Inclisiran▼ – its clinical position in lipid management”, initiated …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3629/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo disease awareness campaign with patient organisation
An anonymous whistleblowing complainant alleged Daiichi Sankyo initiated and conducted a “get a cholesterol test” disease awareness campaign with a patient organisation and that not all related…
Clauses: NONE
2022 🔒 Subscribe
← Prev 4 5 6 7 8 9 10 Next → Page 7 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews